The Power Of



Innovating novel combination
therapies to empower the immune
system to recognize and attack cancer

SYNC-T Personalized In Situ Combination Multi-Target Cancer Therapy

The SYNC-T solid tumor therapy platform is personalized and performed in situ (within the body).  It is a first-in-class therapy that uniquely combines partial oncolysis of a tumor with infusion of a multi-target biologic drug directly into the tumor. This method is designed to simultaneously address numerous immune suppression mechanisms while also being immunostimulatory. The synergistic approach can lead to T cell activation and proliferation. Patient-specific T cells can then migrate and attack tumors systemically throughout the body.

Play Video

SYNC-T Animation: How it Works

Syncromune® is at the forefront of developing personalized immunotherapies designed to help patients with advanced cancer. Our desire to develop solutions for patients with unmet needs drives us every day.

Disclaimers: The content on this website is intended for healthcare professionals. The compounds and their uses mentioned on this website are investigational and have not been determined safe and effective by the relevant regulatory authorities, including the US Food and Drug Administration or other applicable agencies in other countries.

2919 E. Commercial Blvd.
Fort Lauderdale, FL 33308